Calidi Biotherapeutics Inc (CLDI)
0.2304
-0.01
(-4.79%)
USD |
NYAM |
May 17, 16:00
0.2304
0.00 (0.00%)
After-Hours: 20:00
Calidi Biotherapeutics Revenue (Quarterly)
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
Date | Value |
---|---|
December 31, 2021 | 0.405M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
0.405M
Minimum
Dec 2021
0.405M
Maximum
Dec 2021
0.405M
Average
0.405M
Median
Dec 2021
Revenue (Quarterly) Benchmarks
Minerva Neurosciences Inc | -- |
Viking Therapeutics Inc | -- |
CytomX Therapeutics Inc | 41.46M |
Genprex Inc | -- |
Janux Therapeutics Inc | 1.252M |
Revenue (Quarterly) Related Metrics
Net Income (Quarterly) | -8.229M |
Total Expenses (Quarterly) | 9.208M |
EPS Diluted (Quarterly) | -0.2317 |
Enterprise Value | 9.518M |
Earnings Yield | -319.8% |